Insulin glargine biosimilar (Tonghua Dongbao Pharmaceutical)
甘精胰岛素生物类似药（通化东宝）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameInsulin glargine biosimilar (Tonghua Dongbao Pharmaceutical)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2019/12/06
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTonghua Dongbao Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesMeitheal Pharmaceuticals IncTonghua Dongbao Pharmaceutical Co LtdNanjing King-Friend Biochemical Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC Code
Related LinksN/A